10:00 Uhr |
Welcome
Matthias Guckenberger, University Hospital Zurich |
Session I – MR-Enhanced Treatment of GU Cancers
Moderated by Daniel M. Aebersold and Kathrin Zaugg |
10:15 Uhr |
Clinical Benefit of MR-only Radiotherapy
Thomas Zilli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland |
10:40 Uhr |
MR-guided Radiotherapy in Primary and Oligometastatic Prostate Cancer
Alison Tree, The Royal Marsden, London, UK |
11:05 Uhr |
MR-guided Radiotherapy in Recurrent Prostate Cancer
Mohamed Shelan, Inselspital, Bern, Switzerland |
11:30 Uhr |
MR-Enhanced Stereotactic Irradiation of Renal Cell Carcinoma
Guilia Marvaso, European Institute of Oncology, Milan, Italy |
11:55 Uhr |
Lunch Break |
Session II – Further Clinical Applications of MR-Enhanced Radiotherapy
Moderated by Anca-Ligia Grosu and Pelagia Tsoutsou |
13:00 Uhr |
MR-Based Radiation Therapy for Rectal Cancer
Luca Boldrini, University Polyclinic A. Gemelli – IRCCS, Rome, Italy |
13:25 Uhr |
MR-Based Radiation Therapy of Pancreatic and Hepatobiliary Tumors
Jakob Liermann, University Hospital, Heidelberg, Germany |
13:50 Uhr |
Applications of MR-guided Brachytherapy
Stefanie Corradini, LMU-Hospital, Munich, Germany |
14:15 Uhr |
Coffee Break |
Session III – Current State and Future Potential of MR-Enhanced Radiotherapy
Moderated by Fernanda Herrera and Susanne Rogers |
14:45 Uhr |
MR-guided Adaptive Radiotherapy – Beyond Geometric Adaptation
Daniela Thorwarth, University Hospital, Tübingen, Germany |
15:10 Uhr |
Feasibility Study of a MR-/sCT-only Workflow for Intracranial Stereotactic Treatments
Christoph Bert, University Hospital, Erlangen, Germany |
15:35 Uhr |
MR-based Tumor Growth Model to Personalize Radiation Therapy
Sarah Brüningk, Inselspital, Bern, Switzerland |
16:00 Uhr |
MR-informed Radiotherapy – Recent Developments and Innovation Space at USZ
Sebastian M. Christ, University Hospital Zurich, Zurich, Switzerland |
16:30 Uhr |
End of Event |